Case-control study identifies K. pneumoniae proteins associated with lack of neonatal sepsis

Neonatal sepsis caused by Klebsiella pneumoniae is a major cause of under-five mortality in sub-Saharan Africa, and the rapid increase of infections caused by bacteria resistant to most or all available antimicrobials severely limits treatment options. An effective, maternally-administered vaccine could make a substantial reduction in neonatal sepsis and associated negative outcomes, as well as reduce the overall need for antimicrobials, a key driver of antimicrobial resistance. This study explored the potential for a maternally administered protein-based vaccine to provide neonatal protection via antibodies transferred transplacentally and through breastfeeding. A case-control study of mother and baby dyads was designed with 20 neonates developing K. pneumoniae sepsis and 80 uninfected control neonates to analyse breastmilk IgA, cord blood IgG and maternal serum IgA and IgG antibodies on a protein microarray with 161 selected K. pneumoniae proteins representing 152 unique genes. This analysis identified a set of proteins eliciting antibody responses, some associated with lack of K. pneumoniae sepsis, that indicate the presence of potentially protective antibodies. This is an essential first step in exploring surface protein accessibility, despite the large capsule. We highlight fimbrial structures, conjugative pili, and small lipoproteins associated with large outer membrane complexes as potential protein vaccine targets. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=199 HEIGHT=200 SRC="FIGDIR/small/26349300v1_ufig1.gif" ALT="Figure 1"> View larger version (40K): [email protected]@13f7cd2org.highwire.dtl.DTLVardef@11c0042org.highwire.dtl.DTLVardef@154fe09_HPS_FORMAT_FIGEXP M_FIG C_FIG